http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013515682-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013515682-A |
| titleOfInvention | Pharmaceutical use of 2 ', 2-bisthiazole non-nucleoside compounds as hepatitis C virus inhibitors |
| abstract | The present invention relates to a general formula (I) as a hepatitis C virus inhibitor: A pharmaceutical use of a 2 ′, 2-bisthiazole non-nucleoside compound represented by the formula: The 2 ′, 2-bisthiazole non-nucleoside compound can inhibit HCV replication, has anti-hepatitis C virus activity, and can be used for the treatment of hepatitis C. |
| priorityDate | 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.